Metsera
About:
Metsera develops oral and injectable therapies for obesity and metabolic diseases.
Website: https://metsera.com
Twitter/X: MetseraInc
Top Investors: RA Capital Management, Wellington Management, F-Prime Capital, ARCH Venture Partners, Fidelity
Description:
Metsera is a clinical-stage biopharmaceutical company that focuses on creating innovative therapies for obesity and metabolic conditions. The company advances a range of oral and injectable treatment options while integrating proprietary health technology tools for personalized care.
Total Funding Amount:
$505M
Headquarters Location:
New York, New York, United States
Founded Date:
2022-01-01
Founders:
Whit Bernard
Number of Employees:
11-50
Last Funding Date:
2024-11-13
IPO Status:
Private
© 2025 bioDAO.ai